AMBERSTONE BIOSCIENCES, INC. — Form D/A
AMBERSTONE BIOSCIENCES, INC. of LAGUNA HILLS, CA, a company, filed a Form D amendment with the SEC on 2021-12-20. The offering totals $12.0M, of which $6.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2021-12-20
- Form: D/A
- Accession: 0001896218-21-000003
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $12.0M
- Amount sold: $6.0M
- Remaining: $6.0M
- Investors: 6
- Date of first sale: 2021-11-09
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-425686
Issuer
- Name: AMBERSTONE BIOSCIENCES, INC.
- CIK: 0001896218
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 23181 VERDUGO DR, LAGUNA HILLS, CA, 92653
- Phone: 9492697918
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Yonglei Guikai Shang | Director | Laguna Hills, CA |
| George Guikai Wu | Director | Laguna Hills, CA |
| Weian Guikai Zhao | Director | Laguna Hills, CA |
| Yonglei Guikai Shang | Executive Officer | Laguna Hills, CA |
| George Guikai Wu | Executive Officer | Laguna Hills, CA |
Other filings by this issuer (1)
More